REQUEST A DEMO
Total
USD $0.00
Search more companies

Biogenericos S A S (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Biogenericos S A S Profile Updated: April 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Biogenericos S A S is a company in Colombia, with a head office in Bogota D.C.. It operates in the Pharmaceutical Preparation Manufacturing industry. Biogenericos S A S was incorporated on December 27, 1996. 3 (2026) employees currently work for Biogenericos S A S. From the latest financial highlights, Biogenericos S A S reported a net sales revenue increase of 7.53% in 2025. Its’ total assets recorded a growth of 42.94%. The net profit margin of Biogenericos S A S increased by 8.46% in 2025.

Headquarters
Cr 49 91- 28
Bogota D.C.; Bogota D.C; Postal Code: 0821

Contact Details: Purchase the Biogenericos S A S report to view the information.

Basic Information
Total Employees:
Purchase the Biogenericos S A S report to view the information.
Financial Auditors:
Purchase the Biogenericos S A S report to view the information.
Incorporation Date:
December 27, 1996
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Biogenericos S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
7.53%
Total Operating Revenue
7.53%
Operating Profit
194.37%
Net Profit/Loss for the Period
75.43%
Total Assets
42.94%
Total Equity
21.84%
Operating Profit Margin
36.34%
Net Profit Margin
8.46%
Return on Equity (ROE)
5.88%
Quick Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?